These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 10637249

  • 1. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
    Socié G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, Sullivan KM, Rowlings PA, Kingma DW, Banks PM, Travis WD, Witherspoon RP, Sanders J, Jaffe ES, Horowitz MM.
    J Clin Oncol; 2000 Jan; 18(2):348-57. PubMed ID: 10637249
    [Abstract] [Full Text] [Related]

  • 2. Solid cancers after bone marrow transplantation.
    Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF, Boice JD.
    N Engl J Med; 1997 Mar 27; 336(13):897-904. PubMed ID: 9070469
    [Abstract] [Full Text] [Related]

  • 3. Secondary malignancies after bone marrow transplantation in adults.
    Lowsky R, Lipton J, Fyles G, Minden M, Meharchand J, Tejpar I, Atkins H, Sutcliffe S, Messner H.
    J Clin Oncol; 1994 Oct 27; 12(10):2187-92. PubMed ID: 7931488
    [Abstract] [Full Text] [Related]

  • 4. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.
    Rowlings PA, Curtis RE, Passweg JR, Deeg HJ, Socié G, Travis LB, Kingma DW, Jaffe ES, Sobocinski KA, Horowitz MM.
    J Clin Oncol; 1999 Oct 27; 17(10):3122-7. PubMed ID: 10506608
    [Abstract] [Full Text] [Related]

  • 5. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastoors B, Keller A, Kurtz JM, Chapuis B.
    J Clin Oncol; 1996 Feb 27; 14(2):579-85. PubMed ID: 8636774
    [Abstract] [Full Text] [Related]

  • 6. Solid cancers after bone marrow transplantation.
    Bhatia S, Louie AD, Bhatia R, O'Donnell MR, Fung H, Kashyap A, Krishnan A, Molina A, Nademanee A, Niland JC, Parker PA, Snyder DS, Spielberger R, Stein A, Forman SJ.
    J Clin Oncol; 2001 Jan 15; 19(2):464-71. PubMed ID: 11208840
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 15; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 8. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
    Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W, McDonald GB, Mori M, Schoch G, Hansen JA.
    J Clin Oncol; 1993 Feb 15; 11(2):304-13. PubMed ID: 8426208
    [Abstract] [Full Text] [Related]

  • 9. Development of secondary anaplastic oligoastrocytoma after matched unrelated bone marrow transplantation in a child with acute myeloid leukemia.
    Panigrahi S, Das M, Stagler D, Konstantini S, Gmori M, Slavin S, Nagler A.
    Acta Haematol; 2003 Feb 15; 109(4):196-8. PubMed ID: 12853693
    [Abstract] [Full Text] [Related]

  • 10. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
    Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF, Deeg HJ.
    Blood; 1999 Oct 01; 94(7):2208-16. PubMed ID: 10498590
    [Abstract] [Full Text] [Related]

  • 11. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 12. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC.
    Bone Marrow Transplant; 1996 Jan 01; 17(1):13-8. PubMed ID: 8673048
    [Abstract] [Full Text] [Related]

  • 13. Growth in children following irradiation for bone marrow transplantation.
    Bushhouse S, Ramsay NK, Pescovitz OH, Kim T, Robison LL.
    Am J Pediatr Hematol Oncol; 1989 Jan 01; 11(2):134-40. PubMed ID: 2665547
    [Abstract] [Full Text] [Related]

  • 14. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Roy DC, Gonin R, Alyea EP, Bélanger R, Gyger M, Perreault C, Bonny Y, Lerra I, Murray C.
    J Clin Oncol; 1995 Jul 01; 13(7):1704-13. PubMed ID: 7602361
    [Abstract] [Full Text] [Related]

  • 15. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
    Zecca M, Pession A, Messina C, Bonetti F, Favre C, Prete A, Cesaro S, Porta F, Mazzarino I, Giorgiani G, Rondelli R, Locatelli F.
    J Clin Oncol; 1999 Jun 01; 17(6):1838-46. PubMed ID: 10561223
    [Abstract] [Full Text] [Related]

  • 16. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Jun 01; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 17. Growth in children after bone marrow transplantation for acute leukemia.
    Huma Z, Boulad F, Black P, Heller G, Sklar C.
    Blood; 1995 Jul 15; 86(2):819-24. PubMed ID: 7606013
    [Abstract] [Full Text] [Related]

  • 18. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, Iida H, Uchida T, Ikegame K, Takahashi S, Kato K, Kawa K, Nagamura-Inoue T, Morishima Y, Sakamaki H, Kodera Y, Japan Society for Hematopoietic Cell Transplantation.
    Ann Oncol; 2014 Feb 15; 25(2):435-41. PubMed ID: 24399081
    [Abstract] [Full Text] [Related]

  • 19. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
    Deeg HJ, Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R.
    Blood; 1996 Jan 01; 87(1):386-92. PubMed ID: 8547667
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.